Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
SEC Accession No. 0000902664-23-001925
Filing Date
2023-02-21
Accepted
2023-02-21 13:19:48
Documents
17

Document Format Files

Seq Description Document Type Size
1 ANIKA THERAPEUTICS, INC. p23-0964dfan14a.htm DFAN14A 69944
2 GRAPHIC image_004.jpg GRAPHIC 7637
3 GRAPHIC image_005.jpg GRAPHIC 35022
4 GRAPHIC image_020.jpg GRAPHIC 16083
5 GRAPHIC image_021.jpg GRAPHIC 22258
6 GRAPHIC image_022.jpg GRAPHIC 4592
7 GRAPHIC image_023.jpg GRAPHIC 22422
8 GRAPHIC image_024.jpg GRAPHIC 26052
9 GRAPHIC image_025.jpg GRAPHIC 27111
10 GRAPHIC image_026.jpg GRAPHIC 54000
11 GRAPHIC image_006.jpg GRAPHIC 35501
12 GRAPHIC image_007.jpg GRAPHIC 6410
13 GRAPHIC image_009.jpg GRAPHIC 22228
14 GRAPHIC image_010.jpg GRAPHIC 34239
15 GRAPHIC image_028.jpg GRAPHIC 35906
16 GRAPHIC image_029.jpg GRAPHIC 9200
17 GRAPHIC image_002.jpg GRAPHIC 31766
  Complete submission text file 0000902664-23-001925.txt   611386
Mailing Address 32 WIGGINS AVENUE BEDFORD MA 01730
Business Address 32 WIGGINS AVENUE BEDFORD MA 01730 (781) 457-9000
Anika Therapeutics, Inc. (Subject) CIK: 0000898437 (see all company filings)

EIN.: 043145961 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DFAN14A | Act: 34 | File No.: 001-14027 | Film No.: 23646890
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address 515 MADISON AVENUE 9TH FLOOR NEW YORK NY 10022
Business Address 515 MADISON AVENUE 9TH FLOOR NEW YORK NY 10022 718-570-6018
Caligan Partners LP (Filed by) CIK: 0001727492 (see all company filings)

EIN.: 822603419 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DFAN14A